Hanns-Eberhard Erle
Corporate Officer/Principal bij Cardiorentis AG
Oorsprong van het eerstegraads netwerk van Hanns-Eberhard Erle
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Cardiorentis AG
Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland.
5
| Private Company | Pharmaceuticals: Major | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Hanns-Eberhard Erle via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
University of St. Gallen | College/University | Graduate Degree | |
Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
University of Zurich | College/University | Graduate Degree | |
DiNAQOR AG
DiNAQOR AG BiotechnologyHealth Technology DiNAQOR AG is a Swiss genetic medicine platform company that focuses on developing innovative solutions for patients with severe, inherited forms of heart disease. The private company is based in Pfäffikon, Switzerland, and has additional presence in Massachusetts and other locations. The company's lead preclinical program, DINA-001, is aimed at treating mybpc3-linked cardiomyopathy. Founded in 2019, the CEO of DiNAQOR is Johannes Holzmeister. | Biotechnology | Director of Finance/CFO Chief Executive Officer |
Statistieken
Internationaal
Zwitserland | 4 |
Duitsland | 2 |
Sectoraal
Consumer Services | 4 |
Health Technology | 2 |
Operationeel
Director/Board Member | 3 |
Director of Finance/CFO | 2 |
Graduate Degree | 2 |
Chief Executive Officer | 2 |
Chairman | 2 |
Sterkste connecties
Insiders | |
---|---|
Reto Wittwer | 4 |
Johannes Holzmeister | 2 |
Markus Meyer | 2 |
Alexander Goubarev | 1 |
Carole Tep | 1 |
- Beurs
- Insiders
- Hanns-Eberhard Erle
- Bedrijfsconnecties